Suntrust Banks’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $897K | Buy |
11,763
+719
| +7% | +$54.8K | ﹤0.01% | 767 |
|
|
2019
Q2 | $969K | Buy |
11,044
+10
| +0.1% | +$877 | 0.01% | 783 |
|
|
2019
Q1 | $999K | Sell |
11,034
-351
| -3% | -$31.8K | 0.01% | 757 |
|
|
2018
Q4 | $816K | Sell |
11,385
-1,459
| -11% | -$105K | ﹤0.01% | 752 |
|
|
2018
Q3 | $1.23M | Sell |
12,844
-1,485
| -10% | -$142K | 0.01% | 693 |
|
|
2018
Q2 | $1.36M | Buy |
14,329
+2,818
| +24% | +$268K | 0.01% | 669 |
|
|
2018
Q1 | $1.01M | Sell |
11,511
-3,544
| -24% | -$311K | 0.01% | 717 |
|
|
2017
Q4 | $1.28M | Buy |
15,055
+1,458
| +11% | +$124K | 0.01% | 640 |
|
|
2017
Q3 | $1.18M | Sell |
13,597
-586
| -4% | -$50.7K | 0.01% | 688 |
|
|
2017
Q2 | $1.1M | Sell |
14,183
-759
| -5% | -$58.6K | 0.01% | 631 |
|
|
2017
Q1 | $1.04M | Sell |
14,942
-2,589
| -15% | -$180K | 0.01% | 645 |
|
|
2016
Q4 | $1.04M | Buy |
17,531
+532
| +3% | +$31.4K | 0.01% | 762 |
|
|
2016
Q3 | $1.13M | Buy |
16,999
+9,123
| +116% | +$604K | 0.01% | 722 |
|
|
2016
Q2 | $425K | Buy |
7,876
+248
| +3% | +$13.4K | ﹤0.01% | 1009 |
|
|
2016
Q1 | $393K | Sell |
7,628
-2,450
| -24% | -$126K | ﹤0.01% | 1013 |
|
|
2015
Q4 | $706K | Buy |
+10,078
| New | +$706K | ﹤0.01% | 824 |
|
|
2015
Q3 | – | Sell |
-11,334
| Closed | -$952K | – | 1325 |
|
|
2015
Q2 | $952K | Sell |
11,334
-876
| -7% | -$73.6K | 0.01% | 655 |
|
|
2015
Q1 | $917K | Sell |
12,210
-444
| -4% | -$33.3K | 0.01% | 635 |
|
|
2014
Q4 | $785K | Buy |
12,654
+441
| +4% | +$27.4K | 0.01% | 669 |
|
|
2014
Q3 | $634K | Buy |
12,213
+7,500
| +159% | +$389K | ﹤0.01% | 864 |
|
|
2014
Q2 | $241K | Sell |
4,713
-4,050
| -46% | -$207K | ﹤0.01% | 1296 |
|
|
2014
Q1 | $415K | Buy |
8,763
+3,669
| +72% | +$174K | ﹤0.01% | 1424 |
|
|
2013
Q4 | $221K | Buy |
+5,094
| New | +$221K | ﹤0.01% | 1654 |
|